Dr. Payne joined UniPath in 2009 to lead UniPath's molecular laboratory division and currently serves as Vice President of Molecular Services. She was most recently Director of the Molecular Diagnostic Laboratory of the University of Texas Southwestern Medical Center in Dallas, Texas where she was also Associate Professor of Pathology. She was also Director and a founding member of the Division of Molecular Diagnostics in the Department of Pathology at the University of Texas Medical Branch. Dr. Payne received her Ph.D. in microbiology and immunology from the University of Texas Medical Branch in Galveston, Texas; and performed her post doctoral training at UTMB and the Johnson Space Center in Houston, Texas.
Dr. Payne is nationally recognized in molecular diagnostics, is an active speaker, well published and active member of numerous committees and industry organizations. She has held offices as the Chair of the Training and Education committee for the Association of Molecular Pathology, as Chair of the Molecular Pathology division (2002-2003) for the American Association for Clinical Chemistry (AACC), as the Co-Chair for the NACB Laboratory Practice Guidelines committee on Pharmacogenetics, and was formally a voting member for the Molecular and Clinical Genetics Devices Panel of the Medical Devices Advisory Committee of the Food and Drug Administration (FDA). Dr. Payne is the only U.S. member of the Molecular Diagnostics Committee for the International Federation of Clinical Chemists (IFCC). She is also a member of the Center for Disease Control (CDC) committee on reference materials, is an advisor for the Clinical Laboratory Standards Institute (CLSI), and is a member of Board of Directors for the ABCC. Dr. Payne has authored or co-authored several book chapters, and more than 55 manuscripts, and is on the editorial board for LabMedicine.
Dr. Payne is certified as a clinical laboratory scientist-specialist in Molecular Biology ASCP(MB)CM, Diplomate of Laboratory Management DLMCM(ASCP), is a Fellow of the National Academy of Clinical Biochemistry (FACB) and is board certified by the American Board of Clinical Chemistry in Molecular Diagnostics (DABCC) and by the American Board of Medical Microbiology (DABMM).